Trials / Completed
CompletedNCT04097912
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Persistence and Adherence to Low-Dose Aspirin for Primary and Secondary Prevention of Cardiovascular DiseasE Using OHDSI
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 99,999 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to gather information to what extent patients follow the treatment regimen of low-dose aspirin for primary and secondary prevention of diseases of the heart and blood vessels. Researcher will collect information about the percentage of time a patient has access to the medication, how long patients continue with the medication and of the proportion of patients who switch from dual-antiplatelet therapy (including low-dose aspirin) to a single antiplatelet therapy. The study will make use of secondary healthcare data sources converted in to Observational Medical Outcomes Partnership (OMOP) common data model within the Observational Health Data Sciences and Informatics (OHDSI) network.
Conditions
- Myocardial Infarction
- Stroke (Including Ischaemic Stroke and Transient Ischaemic Attack)
- Unstable Angina
- Angina
- Ischaemic Heart Disease
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetylsalicylic Acid (Aspirin, BAYE4465) | 75-100mg |
Timeline
- Start date
- 2019-09-30
- Primary completion
- 2020-11-15
- Completion
- 2020-11-15
- First posted
- 2019-09-20
- Last updated
- 2021-11-05
Locations
2 sites across 2 countries: Germany, United Kingdom
Source: ClinicalTrials.gov record NCT04097912. Inclusion in this directory is not an endorsement.